Skip to main content
OpenTrials

Clinical trial condition

Non Small Cell Lung Cancer

Explore clinical trials studying Non Small Cell Lung Cancer. Study availability and eligibility vary by location and protocol.

671 public trials 177 recruiting studies
Refine in advanced search Browse all conditions

Non Small Cell Lung Cancer trial results

Recruiting

Adjuvant Therapy Omission for Resected NSCLC Patients With Longitudinal Undetectable MRD

NCT05457049

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • The First People's Hospital of Foshan Foshan, Guangdong, China
  • Guangdong Lung Cancer Institute, Guangdong General Hospital, Guangdong Academy of Medical Sciences Guangzhou, Guangdong, China
  • Shantou Centeral Hospital Shantou, Guangdong, China
  • the First Affiliated Hospital of Shantou University Medical College Shantou, Guangdong, China
View Trial Details
Recruiting

Using Urine Samples to Identify Lung Cancer

NCT06033248

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Memorial Sloan Kettering Basking Ridge (All Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (All Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (All Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk-Commack (All Protocol Activities) Commack, New York, United States
View Trial Details
Recruiting

A Study of KK2269 in Adult Participants With Solid Tumors

NCT06266299

Conditions
Adenocarcinoma Of Esophagus, Advanced Solid Tumor, Bronchial Neoplasms, +18 more
Locations
  • Mayo Clinic Arizona Scottsdale, Arizona, United States
  • City Of Hope National Medical Center Duarte, California, United States
  • Hoag Memorial Hospital Presbyterian Newport Beach, California, United States
  • Mayo Clinic Jacksonville Jacksonville, Florida, United States
View all 32 locations
View Trial Details
Recruiting

A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC

NCT07462377

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +28 more
Locations
  • Sarah Cannon and HCA Research Institute Nashville, Tennessee, United States
  • MD Anderson Cancer Center Houston, Texas, United States
  • Site 105 - START Los Angeles Los Angeles, California, United States
  • Site 104 - START New Jersey East Brunswick, New Jersey, United States
View Trial Details
Recruiting

A Study of Tolododekin Alfa (ANK-101) in Combination With an Anti-PD-1/PD-L1 Antibody in Participants With Advanced Non-Small Cell Lung Cancer

NCT07027514

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Community Health Network Indianapolis, Indiana, United States
  • Barbara Ann Karmanos Cancer Hospital Detroit, Michigan, United States
  • Roswell Park Comprehensive Cancer Center Buffalo, New York, United States
  • Icahn School of Medicine at Mount Sinai New York, United States
View Trial Details

Related conditions